Cargando…
Public health and valorization of genome-based technologies: a new model
BACKGROUND: The success rate of timely translation of genome-based technologies to commercially feasible products/services with applicability in health care systems is significantly low. We identified both industry and scientists neglect health policy aspects when commercializing their technology, m...
Autores principales: | Lal, Jonathan A, Schulte in den Bäumen, Tobias, Morré, Servaas A, Brand, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3296632/ https://www.ncbi.nlm.nih.gov/pubmed/22142533 http://dx.doi.org/10.1186/1479-5876-9-207 |
Ejemplares similares
-
Analysis of Existing International Policy Evidence in Public Health Genomics: Mapping Exercise
por: Syurina, Elena V., et al.
Publicado: (2012) -
Data Protection and Sample Management in Biobanking - A legal dichotomy
por: in den Bäumen, Tobias Schulte, et al.
Publicado: (2010) -
Translational Potential into Health Care of Basic Genomic and Genetic Findings for Human Immunodeficiency Virus, Chlamydia trachomatis, and Human Papilloma Virus
por: Malogajski, Jelena, et al.
Publicado: (2013) -
Integrating open-source technologies to build low-cost information systems for improved access to public health data
por: Yi, Qian, et al.
Publicado: (2008) -
Biobanking and translation of human genetics and genomics for infectious diseases
por: Branković, Ivan, et al.
Publicado: (2014)